View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Myeloma News

SPONSORED CONTENT
Save
SPONSORED CONTENT
May 30, 2024
3 min read
Save

Patient-reported outcomes leveraged to overcome barriers to clinical trial enrollment

Patient-reported outcomes leveraged to overcome barriers to clinical trial enrollment

Participation in cancer-related clinical trials could increase dramatically if researchers screened and recruited individuals using routine care patient-reported outcomes, according to results published in JAMA Oncology.

SPONSORED CONTENT
May 22, 2024
2 min read
Save

Active cancer treatment linked to increased risk for sudden cardiac arrest

Active cancer treatment linked to increased risk for sudden cardiac arrest

Active cancer treatment is associated with increased risk for sudden cardiac death, especially among patients younger than 74 years old and those with a history of heart failure, results from a retrospective study showed.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
May 22, 2024
3 min read
Save

Despite enduring disparities, stem cell transplants expand across all races, ethnicities

Despite enduring disparities, stem cell transplants expand across all races, ethnicities

The amount of autologous and allogeneic hematopoietic stem cell transplants for hematologic disorders has increased over time in tandem with longer survival, according to results of an observational study.

SPONSORED CONTENT
May 21, 2024
5 min read
Save

Racing modified cells against each other in humans may be the next step in gene therapies

Racing modified cells against each other in humans may be the next step in gene therapies

The next evolution of gene therapies may involve pitting T cells with different modifications against one another in a “race” inside a human to determine which edits produce the best results against a tumor, an expert panel predicted.

SPONSORED CONTENT
May 16, 2024
3 min read
Save

AI has ‘promising utility’ to give high-quality, empathetic answers to patient questions

AI has ‘promising utility’ to give high-quality, empathetic answers to patient questions

AI could have the ability to answer some patient questions on cancer instead of clinicians, reducing clinician burdens and improving access to care, according to study results published in JAMA Oncology.

SPONSORED CONTENT
May 14, 2024
5 min read
Save

Understanding patient preferences, values can help overcome barriers to genomic profiling

Understanding patient preferences, values can help overcome barriers to genomic profiling

Michael J. Hall, MD, MS, FASCO, must occasionally remind himself not everyone holds genetics research in the high esteem he does.

SPONSORED CONTENT
May 09, 2024
4 min read
Save

Cancer care can drastically affect employment status, income for working adults

Cancer care can drastically affect employment status, income for working adults

As part of routine screening for financial hardship, clinicians should discuss an individual’s employment, access to paid leave and health insurance coverage when constructing a treatment plan relating to cancer care.

SPONSORED CONTENT
May 07, 2024
2 min read
Save

Online information about liquid biopsies has ‘extensive shortcomings’

Online information about liquid biopsies has ‘extensive shortcomings’

Online resources about liquid biopsies have several deficits that could prevent patients from learning about the test and better understanding , according to findings published in JAMA Network Open.

SPONSORED CONTENT
April 30, 2024
3 min read
Save

Guidelines: Optimizing vaccinations a ‘critical component’ of effective cancer care

Guidelines: Optimizing vaccinations a ‘critical component’ of effective cancer care

New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.

SPONSORED CONTENT
April 16, 2024
2 min read
Save

FDA panel backs residual disease as ‘reasonable surrogate’ endpoint in myeloma trials

FDA panel backs residual disease as ‘reasonable surrogate’ endpoint in myeloma trials

An FDA advisory committee unanimously voted minimal residual disease should be an accepted endpoint for accelerated approval of clinical trials investigating treatments for patients with multiple myeloma.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails